Sawant Harshal, Bihl Ji, Borthakur Alip
Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA.
Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA.
Int J Mol Sci. 2025 Jan 26;26(3):1058. doi: 10.3390/ijms26031058.
Probiotic bacteria are normal inhabitants of a healthy human gut, conferring multiple beneficial effects on the gut and beyond. Under various disease states, the abundance and diversity of beneficial bacteria are significantly decreased, a process called dysbiosis. Among the intra- and extracellular components of probiotics, the extracellular vesicles (EVs) secreted by them have recently garnered significant attention as potential mediators of probiotics' effects on host health. Further, these nanosized particles that encapsulate a wide range of bioactive molecules (proteins, lipids, RNA, and DNA) are standing out as key factors that could mediate gut microbiota-host communication and confer ameliorating effects in experimental inflammatory, metabolic, and cardiovascular disease models. However, a standard protocol of EV isolation from probiotic bacteria, not varying from lab to lab, must be established to achieve consistency in the experimental results in these pre-clinical models. Our current study compared two commonly used methods for EV isolation from biological samples, ultracentrifugation and precipitation, to develop a standard protocol for isolating EVs from the probiotics (LA) a Gram-positive bacterium, and Nissle (EcN) a Gram-negative bacterium. The ultracentrifugation method gave ~1.5-fold higher EV yield for both LA and EcN compared to the precipitation method. Further, EcN released a higher level of EVs compared to LA. EVs were quantified and characterized by nanoparticle-tracking analysis (NTA) and by measuring the specific surface biomarkers using Western blot. Here, we describe our standardized step-by-step protocol for isolating EVs from probiotic bacteria and their characterization.
益生菌是健康人体肠道的正常寄居菌,对肠道及其他方面具有多种有益作用。在各种疾病状态下,有益菌的丰度和多样性会显著降低,这一过程称为生态失调。在益生菌的细胞内和细胞外成分中,它们分泌的细胞外囊泡(EVs)最近作为益生菌对宿主健康影响的潜在介质而备受关注。此外,这些包裹着多种生物活性分子(蛋白质、脂质、RNA和DNA)的纳米级颗粒正成为介导肠道微生物群与宿主通讯并在实验性炎症、代谢和心血管疾病模型中发挥改善作用的关键因素。然而,必须建立一个从益生菌中分离EVs的标准方案,且各个实验室保持一致,以便在这些临床前模型的实验结果中实现一致性。我们目前的研究比较了两种从生物样品中分离EVs的常用方法,即超速离心法和沉淀法,以制定从益生菌(革兰氏阳性菌LA和革兰氏阴性菌Nissle(EcN))中分离EVs的标准方案。与沉淀法相比,超速离心法对LA和EcN的EV产量均高出约1.5倍。此外,EcN释放的EVs水平高于LA。通过纳米颗粒跟踪分析(NTA)以及使用蛋白质免疫印迹法测量特定表面生物标志物对EVs进行定量和表征。在此,我们描述了从益生菌中分离EVs及其表征的标准化分步方案。